More than four hundred King & Spalding lawyers across our litigation, transactional and regulatory teams devote all or a substantial portion of their practice to serving clients in every segment of the Life Sciences and Healthcare sectors.
The comprehensive scope of the practice is unique: from helping to establish the start-ups developing the latest breakthrough drugs and medical devices, to defending the world’s largest pharmaceutical manufacturers in precedent-setting legal challenges, to representing major healthcare systems on their thorniest Medicare/Medicaid litigation or their strategic acquisitions, to counseling on the full spectrum of regulatory matters that these diverse entities face. We fully leverage our ability to draw on our broad experience as we work together to achieve outcomes that best protect and advance the interests of our clients across these sectors.
The lawyers in this group bring exceptionally deep industry and technical knowledge, many with advanced degrees in life sciences and medical fields as well as professional experience as scientists, surgeons, engineers, in-house lawyers and executives, senior regulators at the FDA, HHS and CMS, and enforcement officials at the DOJ.
Named a four time winner of Law 360’s “Practice Group of the Year” (2016-2019), the firm currently represents more than 250 pharmaceutical, biotechnology and medical device manufacturers, including eight of the top 10 pharmaceutical/biotechnology manufacturers and eight of the top 10 medical device manufacturers. We offer clients our unique perspective at every stage of the product life cycle — from emerging growth company counseling on intellectual property, capital-raising transactions, license and corporate partnering agreements, and clinical trials, through FDA approval, manufacturing, marketing, commercial and post-approval regulatory, strategic M&A, and other corporate transactions, to litigation and government and internal investigation matters. Our government affairs lawyers also help our clients in the industry understand and navigate legislative and regulatory developments in Washington, D.C., and in state capitals across the country.
The firm has one of the largest practices in the U.S., representing organizations involved in the delivery of healthcare services and products across all facets of the legal issues they face. We serve the entire spectrum of healthcare institutional providers, practitioners, payors, educators, researchers, inventors, suppliers, investors and manufacturers across the nation.
King & Spalding partner Mark Polston discusses hospital price transparency.Watch Now
K&S launches General Counsel Internal Investigations Decision Tree for the Life Sciences industry, including COVID-19 considerations.Explore Here
At this critical juncture of distribution, our COVID-19 Vaccine Rollout Task Force is drawing on our industry knowledge and client relationships to serve as a guiding light and partner to our clients.Read More
King & Spalding partners Sally Yates and Mike Paulhus discuss key developments in healthcare fraud and abuse enforcement.Watch Now
King & Spalding partner John Barnes discusses best practices when negotiating agreements between healthcare providers and commercial payors.Watch Now
King & Spalding partner Amanda Hayes-Kibreab explains ways that healthcare providers can successfully challenge commercial payors’ reimbursement policies.Watch Now
Stephanie has significant experience assisting health systems, hospitals, home health and hospice companies, skilled nursing facilities, laboratories and inpatient rehabilitation facilities with compliance program assessments and the negotiation and implementation of Corporate Integrity Agreements.Read More
LMG Life Sciences
September 20, 2021
Health Headlines – September 20, 2021
September 7, 2021
Health Headlines – September 7, 2021
August 24, 2021
Arbor Pharmaceuticals to Merge with Azurity Pharmaceuticals
August 11, 2021
Sharecare Acquires Digital On-Demand Platform CareLinx